Skip to main content
Top
Published in: AIDS and Behavior 5/2020

Open Access 01-05-2020 | Human Immunodeficiency Virus | Original Paper

No Evidence of Sexual Risk Compensation Following PrEP Initiation Among Heterosexual HIV Serodiscordant Couples in Kenya and Uganda

Authors: Katrina F. Ortblad, Randy M. Stalter, Elizabeth A. Bukusi, Kenneth Ngure, Andrew Mujugura, Connie Celum, Jared M. Baeten, Renee Heffron

Published in: AIDS and Behavior | Issue 5/2020

Login to get access

Abstract

Recent studies among men who have sex with men suggest that sexual behaviors associated with risk of sexually transmitted infections increase following initiation of pre-exposure prophylaxis (PrEP) for HIV prevention. We used longitudinal data from HIV-uninfected participants (n = 1013) enrolled in an open-label study of PrEP delivered to Ugandan and Kenyan heterosexual HIV serodiscordant couples to understand the association between PrEP initiation and HIV risk-related sexual behaviors among these couples. In the month following PrEP initiation, the mean number of monthly sex acts within couples decreased from 7.9 to 6.9 (mean difference: − 1.1; 95% CI − 1.5, − 0.7) and the proportion of couples having condomless sex decreased from 65% to 32% (percentage point change: − 33%; 95% CI − 37%, − 30%); these behaviors then remained relatively constant over 2 years. We found no evidence of sexual risk compensation following PrEP initiation within African serodiscordant couples. However, roughly a third of couples continued to engage in condomless sex during follow up, emphasizing the importance of continued PrEP use to sustain HIV protection.
Appendix
Available only for authorised users
Literature
1.
go back to reference Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.CrossRef Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.CrossRef
2.
go back to reference Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399–410.CrossRef Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399–410.CrossRef
3.
go back to reference Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367(5):423–34.CrossRef Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367(5):423–34.CrossRef
4.
go back to reference Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2013;381(9883):2083–90.CrossRef Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2013;381(9883):2083–90.CrossRef
5.
go back to reference Pyra M, Brown ER, Haberer JE, Heffron R, Celum C, Bukusi EA, et al. Patterns of oral PrEP adherence and HIV risk among Eastern African women in HIV serodiscordant partnerships. AIDS Behav. 2018;22(11):3718–25.CrossRef Pyra M, Brown ER, Haberer JE, Heffron R, Celum C, Bukusi EA, et al. Patterns of oral PrEP adherence and HIV risk among Eastern African women in HIV serodiscordant partnerships. AIDS Behav. 2018;22(11):3718–25.CrossRef
6.
go back to reference Ortblad KF, Harling G, Chimbindi N, Tanser F, Salomon JA, Bärnighausen T. Does incident circumcision lead to risk compensation? Evidence from a population cohort in KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr. 2019;80(3):269–75.CrossRef Ortblad KF, Harling G, Chimbindi N, Tanser F, Salomon JA, Bärnighausen T. Does incident circumcision lead to risk compensation? Evidence from a population cohort in KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr. 2019;80(3):269–75.CrossRef
7.
go back to reference Hoornenborg E, Coyer L, van Laarhoven A, Achterbergh R, de Vries H, Prins M, et al. Change in sexual risk behaviour after 6 months of pre-exposure prophylaxis use: results from the Amsterdam pre-exposure prophylaxis demonstration project. AIDS. 2018;32(11):1527–32.CrossRef Hoornenborg E, Coyer L, van Laarhoven A, Achterbergh R, de Vries H, Prins M, et al. Change in sexual risk behaviour after 6 months of pre-exposure prophylaxis use: results from the Amsterdam pre-exposure prophylaxis demonstration project. AIDS. 2018;32(11):1527–32.CrossRef
8.
go back to reference Hammack PL, Toolis EE, Wilson BDM, Clark RC, Frost DM. Making meaning of the impact of pre-exposure prophylaxis (PrEP) on public health and sexual culture: narratives of three generations of gay and bisexual men. Arch Sex Behav. 2019;48(4):1041–58.CrossRef Hammack PL, Toolis EE, Wilson BDM, Clark RC, Frost DM. Making meaning of the impact of pre-exposure prophylaxis (PrEP) on public health and sexual culture: narratives of three generations of gay and bisexual men. Arch Sex Behav. 2019;48(4):1041–58.CrossRef
9.
go back to reference Prestage G, Maher L, Grulich A, Bourne A, Hammoud M, Vaccher S, et al. Changes in behavior following PrEP initiation among Australian gay and bisexual men. J Acquir Immune Defic Syndr. 2019;81(1):52–6.CrossRef Prestage G, Maher L, Grulich A, Bourne A, Hammoud M, Vaccher S, et al. Changes in behavior following PrEP initiation among Australian gay and bisexual men. J Acquir Immune Defic Syndr. 2019;81(1):52–6.CrossRef
10.
go back to reference Beymer MR, DeVost MA, Weiss RE, Dierst-Davies R, Shover CL, Landovitz RJ, et al. Does HIV pre-exposure prophylaxis use lead to a higher incidence of sexually transmitted infections? A case-crossover study of men who have sex with men in Los Angeles. California. Sex Transm Infect. 2018;94(6):457–62.CrossRef Beymer MR, DeVost MA, Weiss RE, Dierst-Davies R, Shover CL, Landovitz RJ, et al. Does HIV pre-exposure prophylaxis use lead to a higher incidence of sexually transmitted infections? A case-crossover study of men who have sex with men in Los Angeles. California. Sex Transm Infect. 2018;94(6):457–62.CrossRef
11.
go back to reference Callander D, Park SH, Al-Ajlouni YA, Schneider JA, Khan MR, Safren SA, et al. Condomless group sex is associated with HIV pre-exposure prophylaxis knowledge and interest uptake: a cross-sectional study of gay and bisexual men in Paris, France. AIDS Educ Prev. 2019;31(2):127–35.CrossRef Callander D, Park SH, Al-Ajlouni YA, Schneider JA, Khan MR, Safren SA, et al. Condomless group sex is associated with HIV pre-exposure prophylaxis knowledge and interest uptake: a cross-sectional study of gay and bisexual men in Paris, France. AIDS Educ Prev. 2019;31(2):127–35.CrossRef
12.
go back to reference Quaife M, Vickerman P, Manian S, Eakle R, Cabrera-Escobar MA, Delany-Moretlwe S, et al. The effect of HIV prevention products on incentives to supply condomless commercial sex among female sex workers in South Africa. Health Econ. 2018;27(10):1550–66.CrossRef Quaife M, Vickerman P, Manian S, Eakle R, Cabrera-Escobar MA, Delany-Moretlwe S, et al. The effect of HIV prevention products on incentives to supply condomless commercial sex among female sex workers in South Africa. Health Econ. 2018;27(10):1550–66.CrossRef
13.
go back to reference Grant H, Mukandavire Z, Eakle R, Prudden H, B Gomez G, Rees H, et al. When are declines in condom use while using PrEP a concern? Modelling insights from a Hillbrow, South Africa case study. J Int AIDS Soc. 2017;20(1):21744.CrossRef Grant H, Mukandavire Z, Eakle R, Prudden H, B Gomez G, Rees H, et al. When are declines in condom use while using PrEP a concern? Modelling insights from a Hillbrow, South Africa case study. J Int AIDS Soc. 2017;20(1):21744.CrossRef
14.
go back to reference Mugwanya KK, Donnell D, Celum C, Thomas KK, Ndase P, Mugo N, et al. Sexual behaviour of heterosexual men and women receiving antiretroviral pre-exposure prophylaxis for HIV prevention: a longitudinal analysis. Lancet Infect Dis. 2013;13(12):1021–8.CrossRef Mugwanya KK, Donnell D, Celum C, Thomas KK, Ndase P, Mugo N, et al. Sexual behaviour of heterosexual men and women receiving antiretroviral pre-exposure prophylaxis for HIV prevention: a longitudinal analysis. Lancet Infect Dis. 2013;13(12):1021–8.CrossRef
15.
go back to reference Nakku-Joloba E, Pisarski EE, Wyatt MA, Muwonge TR, Asiimwe S, Celum CL, et al. Beyond HIV prevention: everyday life priorities and demand for PrEP among Ugandan HIV serodiscordant couples. J Int AIDS Soc. 2019;22(1):e25225.CrossRef Nakku-Joloba E, Pisarski EE, Wyatt MA, Muwonge TR, Asiimwe S, Celum CL, et al. Beyond HIV prevention: everyday life priorities and demand for PrEP among Ugandan HIV serodiscordant couples. J Int AIDS Soc. 2019;22(1):e25225.CrossRef
16.
go back to reference Patel RC, Stanford-Moore G, Odoyo J, Pyra M, Wakhungu I, Anand K, et al. “Since both of us are using antiretrovirals, we have been supportive to each other”: facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya. J Int AIDS Soc. 2016;19(1):21134.CrossRef Patel RC, Stanford-Moore G, Odoyo J, Pyra M, Wakhungu I, Anand K, et al. “Since both of us are using antiretrovirals, we have been supportive to each other”: facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya. J Int AIDS Soc. 2016;19(1):21134.CrossRef
17.
go back to reference Whetham J, Taylor S, Charlwood L, Keith T, Howell R, McInnes C, et al. Pre-exposure prophylaxis for conception (PrEP-C) as a risk reduction strategy in HIV-positive men and HIV-negative women in the UK. AIDS Care. 2014;26(3):332–6.CrossRef Whetham J, Taylor S, Charlwood L, Keith T, Howell R, McInnes C, et al. Pre-exposure prophylaxis for conception (PrEP-C) as a risk reduction strategy in HIV-positive men and HIV-negative women in the UK. AIDS Care. 2014;26(3):332–6.CrossRef
18.
go back to reference Ngure K, Baeten JM, Mugo N, Curran K, Vusha S, Heffron R, et al. My intention was a child but I was very afraid: fertility intentions and HIV risk perceptions among HIV-serodiscordant couples experiencing pregnancy in Kenya. AIDS Care. 2014;26(10):1283–7.CrossRef Ngure K, Baeten JM, Mugo N, Curran K, Vusha S, Heffron R, et al. My intention was a child but I was very afraid: fertility intentions and HIV risk perceptions among HIV-serodiscordant couples experiencing pregnancy in Kenya. AIDS Care. 2014;26(10):1283–7.CrossRef
19.
go back to reference Ngure K, Kimemia G, Dew K, Njuguna N, Mugo N, Celum C, et al. Delivering safer conception services to HIV serodiscordant couples in Kenya: perspectives from healthcare providers and HIV serodiscordant couples. J Int AIDS Soc. 2017;20(Suppl 1):21309.PubMedPubMedCentral Ngure K, Kimemia G, Dew K, Njuguna N, Mugo N, Celum C, et al. Delivering safer conception services to HIV serodiscordant couples in Kenya: perspectives from healthcare providers and HIV serodiscordant couples. J Int AIDS Soc. 2017;20(Suppl 1):21309.PubMedPubMedCentral
20.
go back to reference Ngure K, Mugo N, Celum C, Baeten JM, Morris M, Olungah O, et al. A qualitative study of barriers to consistent condom use among HIV-1 serodiscordant couples in Kenya. AIDS Care. 2012;24(4):509–16.CrossRef Ngure K, Mugo N, Celum C, Baeten JM, Morris M, Olungah O, et al. A qualitative study of barriers to consistent condom use among HIV-1 serodiscordant couples in Kenya. AIDS Care. 2012;24(4):509–16.CrossRef
21.
go back to reference Haberer JE, Baeten JM, Campbell J, Wangisi J, Katabira E, Ronald A, et al. Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa. PLOS Medicine. 2013;10(9):e1001511.CrossRef Haberer JE, Baeten JM, Campbell J, Wangisi J, Katabira E, Ronald A, et al. Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa. PLOS Medicine. 2013;10(9):e1001511.CrossRef
22.
go back to reference Roxby AC, Ben-Youssef L, Marx G, Kinoti F, Bosire R, Guthrie B, et al. Dual contraceptive method use in HIV-serodiscordant Kenyan couples. J Fam Plann Reprod Health Care. 2016;42(4):264–70.CrossRef Roxby AC, Ben-Youssef L, Marx G, Kinoti F, Bosire R, Guthrie B, et al. Dual contraceptive method use in HIV-serodiscordant Kenyan couples. J Fam Plann Reprod Health Care. 2016;42(4):264–70.CrossRef
23.
go back to reference Baeten JM, Heffron R, Kidoguchi L, Mugo NR, Katabira E, Bukusi EA, et al. Integrated delivery of antiretroviral treatment and pre-exposure prophylaxis to HIV-1-serodiscordant couples: a prospective implementation study in Kenya and Uganda. PLOS Medicine. 2016;13(8):e1002099.CrossRef Baeten JM, Heffron R, Kidoguchi L, Mugo NR, Katabira E, Bukusi EA, et al. Integrated delivery of antiretroviral treatment and pre-exposure prophylaxis to HIV-1-serodiscordant couples: a prospective implementation study in Kenya and Uganda. PLOS Medicine. 2016;13(8):e1002099.CrossRef
24.
go back to reference Heffron R, Ngure K, Odoyo J, Bulya N, Tindimwebwa E, Hong T, et al. Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in East Africa. Gates Open Res. 2017;6(1):3.CrossRef Heffron R, Ngure K, Odoyo J, Bulya N, Tindimwebwa E, Hong T, et al. Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in East Africa. Gates Open Res. 2017;6(1):3.CrossRef
25.
go back to reference The Kenya HIV Testing Services Guidelines. Nairobi. Kenya: National AIDS and STI Control Programme; 2015. The Kenya HIV Testing Services Guidelines. Nairobi. Kenya: National AIDS and STI Control Programme; 2015.
26.
go back to reference Harrington EK, Dworkin S, Withers M, Onono M, Kwena Z, Newmann SJ. Gendered power dynamics and women’s negotiation of family planning in a high HIV prevalence setting: a qualitative study of couples in western Kenya. Cult Health Sex. 2016;18(4):453–69.CrossRef Harrington EK, Dworkin S, Withers M, Onono M, Kwena Z, Newmann SJ. Gendered power dynamics and women’s negotiation of family planning in a high HIV prevalence setting: a qualitative study of couples in western Kenya. Cult Health Sex. 2016;18(4):453–69.CrossRef
27.
go back to reference Closson K, Dietrich JJ, Lachowsky NJ, Nkala B, Palmer A, Cui Z, et al. Sexual self-efficacy and gender: a review of condom use and sexual negotiation among young men and women in sub-Saharan Africa. J Sex Res. 2018;55(4–5):522–39.CrossRef Closson K, Dietrich JJ, Lachowsky NJ, Nkala B, Palmer A, Cui Z, et al. Sexual self-efficacy and gender: a review of condom use and sexual negotiation among young men and women in sub-Saharan Africa. J Sex Res. 2018;55(4–5):522–39.CrossRef
31.
go back to reference Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.CrossRef Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.CrossRef
32.
go back to reference Ramachandran S, Mishra S, Condie N, Pickles M. How do HIV-negative individuals in sub-Saharan Africa change their sexual risk behaviour upon learning their serostatus? A systematic review. Sex Transm Infect. 2016;92(8):571–8.CrossRef Ramachandran S, Mishra S, Condie N, Pickles M. How do HIV-negative individuals in sub-Saharan Africa change their sexual risk behaviour upon learning their serostatus? A systematic review. Sex Transm Infect. 2016;92(8):571–8.CrossRef
33.
go back to reference Allen S, Meinzen-Derr J, Kautzman M, Zulu I, Trask S, Fideli U, et al. Sexual behavior of HIV discordant couples after HIV counseling and testing. AIDS. 2003;17(5):733–40.CrossRef Allen S, Meinzen-Derr J, Kautzman M, Zulu I, Trask S, Fideli U, et al. Sexual behavior of HIV discordant couples after HIV counseling and testing. AIDS. 2003;17(5):733–40.CrossRef
34.
go back to reference Baltagi B. Econometric analysis of panel data. 5th ed. Chichester: Wiley; 2008. Baltagi B. Econometric analysis of panel data. 5th ed. Chichester: Wiley; 2008.
35.
go back to reference Bärnighausen T, Oldenburg C, Tugwell P, Bommer C, Ebert C, Barreto M, et al. Quasi-experimental study designs series-paper 7: assessing the assumptions. J Clin Epidemiol. 2017;89:53–66.CrossRef Bärnighausen T, Oldenburg C, Tugwell P, Bommer C, Ebert C, Barreto M, et al. Quasi-experimental study designs series-paper 7: assessing the assumptions. J Clin Epidemiol. 2017;89:53–66.CrossRef
36.
go back to reference Klusmann D. Sexual motivation and the duration of partnership. Arch Sex Behav. 2002;31(3):275–87.CrossRef Klusmann D. Sexual motivation and the duration of partnership. Arch Sex Behav. 2002;31(3):275–87.CrossRef
Metadata
Title
No Evidence of Sexual Risk Compensation Following PrEP Initiation Among Heterosexual HIV Serodiscordant Couples in Kenya and Uganda
Authors
Katrina F. Ortblad
Randy M. Stalter
Elizabeth A. Bukusi
Kenneth Ngure
Andrew Mujugura
Connie Celum
Jared M. Baeten
Renee Heffron
Publication date
01-05-2020
Publisher
Springer US
Published in
AIDS and Behavior / Issue 5/2020
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-019-02720-4

Other articles of this Issue 5/2020

AIDS and Behavior 5/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.